BACKGROUND	QVA149 is a once-daily ( o.d. ) inhaled dual bronchodilator containing a fixed-dose combination of the long-acting 2-agonist indacaterol and the long-acting muscarinic antagonist glycopyrronium for the treatment of COPD .\